Fisetin for Cognitive Function

Research suggests that fisetin, a naturally occurring plant flavonoid, may support cognitive function and offer neuroprotective effects across a range of preclinical models, including Alzheimer's disease, schizophrenia, seizure-induced memory impairment, traumatic brain injury, and liver disease-related brain dysfunction. Studies indicate that these potential benefits appear to operate through multiple biological mechanisms simultaneously, including reduction of neuroinflammation, suppression of oxidative stress, preservation of synaptic function, and upregulation of memory-related signaling proteins such as CREB and BDNF. The current body of evidence consists entirely of animal studies, computational analyses, and reviews of preclinical research, with no published human clinical trials specifically examining fisetin's effects on cognitive function, which represents a substantial limitation in drawing conclusions about its relevance for people. One fisetin-derived compound, CMS121, has progressed toward early-stage human trials for Alzheimer's disease, suggesting that clinical research in this area may be forthcoming, but at present the evidence for cognitive benefits in humans remains preliminary and speculative.